Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 284

Status in the House for the 91st Legislature (2019 - 2020)

Description

Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.

Authors (15)

Actions

House

01/22/2019
Introduction and first reading, referred to Commerce
pg. 93 Intro
01/24/2019
Authors added Loeffler and Dehn
pg. 120
03/11/2019
Committee report, to adopt as amended and re-refer to Health and Human Services Policy
pg. 937a
03/13/2019
Committee report, to adopt and re-refer to Judiciary Finance and Civil Law Division
pg. 1013
03/20/2019
Author added Persell
pg. 1510
04/01/2019
Author added Bierman
pg. 1785